- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00932178
Calmer Life: A Worry Reduction Program for Older Adults
January 18, 2018 updated by: Melinda Stanley, Baylor College of Medicine
Calmer Life is a research study for older adults with anxiety.
In the program participants will have the opportunity to learn skills that may help cope with anxiety.
Participants have the option of including religion and spirituality into the skill.
Skills participants can learn include: how to relax, how to change the way you think about things, and how to solve problems more effectively.
Study Overview
Detailed Description
Preliminary work in a related study (H-22763) suggests that a significant percentage of older patients think that incorporating religion and/or spirituality into counseling is important.
Based on data from this study, available scholarly literature, and input from consultants, we have developed an initial version of Calmer Life that is sufficiently flexible to incorporate a range of religious and spiritual beliefs and coping skills based on each patient's unique values and beliefs.
The manual for this treatment includes intervention components from evidence-based treatment for late-life anxiety (H-23798; H-15958), suggested strategies for incorporating religion or spirituality into the coping skills for anxiety and depression, and spiritually-based interventions (e.g., forgiveness, gratitude).
Patients have a choice to include or not include religious or spiritually based components.
The proposed project will begin to test this broad spiritually based CBT for older adults (Calmer Life) with Generalized Anxiety Disorder (GAD) with or without depression.
Further modifications to the Calmer Life manual and in the treatment approach will be made based on patient, clinician, and consultant input.
Study Type
Interventional
Enrollment (Actual)
32
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77030
- Michael E DeBakey VA Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age 50+;
- A principal or co-principal diagnosis of General Anxiety Disorder;
- Interest in receiving CBT for anxiety/depression with the option of including religion and spirituality;
- Must be English speaking
Exclusion Criteria:
- Active suicidal intent;
- Current psychosis or bipolar disorder;
- Substance abuse within the last month
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Calmer Life
Skills-based intervention to reduce anxiety and worry in adults age 50+.
|
Calmer Life is a modified version of an existing Cognitive Behavioral Treatment manual.
Participants have the option of including religion and spirituality into coping skills taught as a way of treating anxiety with or without depression in older adults.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Geriatric Depression Scale (GDS), Geriatric Anxiety Inventory (GAI), Penn State Worry Questionnaire (PSWQ-A), State-Trait Anxiety Inventory (STAI)
Time Frame: Baseline, 1-month, 2-month, 3-month, and 6-month
|
Baseline, 1-month, 2-month, 3-month, and 6-month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Melinda A. Stanley, PhD, Michael E. DeBakey VA Medical Center
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2009
Primary Completion (ACTUAL)
February 1, 2016
Study Completion (ACTUAL)
February 1, 2016
Study Registration Dates
First Submitted
July 1, 2009
First Submitted That Met QC Criteria
July 1, 2009
First Posted (ESTIMATE)
July 3, 2009
Study Record Updates
Last Update Posted (ACTUAL)
January 23, 2018
Last Update Submitted That Met QC Criteria
January 18, 2018
Last Verified
January 1, 2018
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- MIRECC006
- VA ID Number: 09E02.H (OTHER: MEDVAMC Research & Development Committe)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anxiety
-
AstraZenecaCompletedAnxiety Disorders | Anxiety | Anxiety Neuroses | Anxiety StatesUnited States
-
Prisma Health-UpstateCompletedAnxiety | Anxiety, Separation | Separation Anxiety | Anxiety Generalized
-
Ann & Robert H Lurie Children's Hospital of ChicagoUniversity of California, Los Angeles; University of CincinnatiRecruitingAnxiety, Separation | Anxiety, Social | Anxiety, GeneralizedUnited States
-
Yale UniversityNational Institute of Mental Health (NIMH)Active, not recruitingGeneralized Anxiety Disorder | Anxiety Disorder of Childhood | Separation Anxiety Disorder of Childhood | Social Anxiety Disorder of ChildhoodUnited States
-
Nazife Begüm KARANCompletedDental Anxiety | Sedative; Anxiety DisorderTurkey
-
Loyola UniversityCompletedAnxiety | Anxiety State | Procedural AnxietyUnited States
-
Eli Lilly and CompanyCompletedAnxiety Neuroses | Anxiety States, Neurotic | Neuroses, AnxietyUnited States, Mexico, South Africa
-
West University of TimisoaraUnknownAnxiety Disorder/Anxiety StateRomania
-
Dr. Nazanin AlaviActive, not recruitingGeneralized Anxiety Disorder | AnxietyCanada
-
ProofPilotFisher WallaceActive, not recruitingGeneralized Anxiety Disorder | Anxiety | Generalized AnxietyUnited States
Clinical Trials on Calmer Life
-
University of British ColumbiaWomen's Health Research Institute of British ColumbiaRecruiting
-
Children's & Women's Health Centre of British ColumbiaCompleted
-
McGill University Health Centre/Research Institute...Quebec Breast Cancer FoundationNot yet recruiting
-
Glostrup University Hospital, CopenhagenLundbeck Foundation; Sygekassernes HelsefondCompletedPhysical Activity | Sedentary Behavior | Life StyleDenmark
-
Roswell Park Cancer InstituteTerminatedQuality of LifeUnited States
-
Makerere UniversityUnknown
-
Tumor Center RegensburgGerman Cancer AidCompletedQuality of Life | Breast Cancer | Breast NeoplasmsGermany
-
Sidney Kimmel Cancer Center at Thomas Jefferson...RecruitingGlioblastoma | WHO Grade III Glioma | WHO Grade II GliomaUnited States
-
AB Biotics, SACompletedModerate HypercholesterolemiaFrance
-
Wake Forest University Health SciencesWithdrawnLung Metastases | Extensive Stage Small Cell Lung Cancer | Recurrent Small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Recurrent Malignant Mesothelioma | Advanced Malignant Mesothelioma